Currently Viewing:
Newsroom
Currently Reading
Researchers Explore Convergence Insufficiency, Cognitive Impairment in Parkinsonian Disorders
August 31, 2019 – AJMC Staff
Coffee Consumption Linked to Less Severe Tremors in Men With Parkinson
August 22, 2019 – Christina Mattina
Pain Treatment for Patients With Parkinson an Unmet Need
August 20, 2019 – Allison Inserro
Researchers Seek to Determine Genetic Variability in Parkinson Progression
August 17, 2019 – AJMC Staff
Estrogen Therapy Suggested to Help Treat Parkinson Symptoms Based on Mouse Model
August 15, 2019 – Christina Mattina
Survey: Caregivers of Patients With PD Note Nonmotor Symptoms More Often Than Patients
August 10, 2019 – Allison Inserro
Study Compares Motivation to Participate in Parkinson Disease Genetic Research Across Ethnicities
August 07, 2019 – Christina Mattina
Comorbid Psychosis Associated With More Severe Parkinson Disease, Longer Hospital Stays
July 31, 2019 – Christina Mattina
Abnormal Lung Function Found in Patients With Early-Stage Parkinson Disease
July 25, 2019 – Christina Mattina

Researchers Explore Convergence Insufficiency, Cognitive Impairment in Parkinsonian Disorders

AJMC Staff
The relationship between cognitive impairment and symptomatic convergence insufficiency in Parkinsonian disorders has not been previously investigated.
Convergence insufficiency (CI) in Parkinsonian disorders causes disabling visual symptoms during close-up work or reading, usually manifesting as double or blurred vision; these vision problems are more common in patients who report cognitive symptoms. The relationship between cognitive impairment and symptomatic convergence insufficiency in Parkinsonian disorders has not been previously investigated. Researchers recently sought to determine if symptomatic CI, as opposed to asymptomatic CI, could serve as a marker of Parkinson cognitive impairment.

Twenty-four patients—18 with Parkinson, 5 with progressive supranuclear palsy, and 1 with multiple system atrophy—were included. Researchers collected objective findings of convergence insufficiency on neuro-ophthalmologic examination and recorded subjective visual symptoms and cognitive complaints. Objective measures included a near point of convergence (NPC) of ≥10 cm or a near/distance disparity of ≥10 prism diopters of an exotropia. The presence of CI, the NPC in centimeters, and subjective reports of visual symptoms were recorded from the medical record. The Self-Administered Gerocognitive Examination was used as a global cognitive screening measure.

Most (70.8%) had visual symptoms attributed to CI (n = 17); the rest (n = 7) had asymptomatic CI with visual complaints due to other causes (eg, exotropia, saccadic deficiency, dry eye). Three-quarters reported subjective cognitive complaints and 54.1% met SAGE criteria for cognitive impairment (total score <17).

Logistic regression models demonstrated no significant relationship between symptomatic CI status and cognitive impairment (P = .29). However, there was a significant relationship between NPC and cognitive impairment, using linear regression, even when controlling for age, education, and disease duration (P = .038). NPC was greater for those with cognitive impairment (x = 18.4 cm), compared to those who were cognitively intact (x = 12.5 cm, P = .003).

The group had lived with the diseases for a mean of 9.1 years at the time of chart review and were at higher risk of cognitive impairment, but the researchers noted there was no significant difference in disease duration between those who were cognitively impaired and those who were not.

The authors wrote that clinicians should suspect cognitive impairment in patients with objective findings of CI, whether symptomatic or not. The severity of CI may serve as an additional marker for cognitive impairment in Parkinsonian conditions, separate from age, and disease duration, and there may be a shared mechanism of dysfunction that deserves further research, they said.

Reference

Holden SK, Van Dok E, Pelak VS.  Co-occurrence of convergence insufficiency and cognitive impairment in parkinsonian disorders: A pilot study [published online August 9, 2019]. Front Neurol. doi: 10.3389/fneur.2019.00864

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up